PYXS
Income statement / Annual
Last year (2024), Pyxis Oncology, Inc.'s total revenue was $16.15 M,
and the percentage change from the previous year is not available.
In 2024, Pyxis Oncology, Inc.'s net income was -$77.33 M.
See Pyxis Oncology, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$16.15 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$475.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$15.67 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0.97
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$58.75 M
|
$49.59 M
|
$86.13 M
|
$51.05 M
|
$9.05 M
|
$1.22 M
|
| General & Administrative Expenses |
$25.42 M
|
$32.61 M
|
$37.35 M
|
$18.66 M
|
$3.85 M
|
$1.66 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$25.42 M
|
$32.61 M
|
$37.35 M
|
$18.66 M
|
$3.85 M
|
$1.66 M
|
| Other Expenses |
$20.96 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$105.13 M
|
$82.20 M
|
$123.48 M
|
$69.72 M
|
$12.89 M
|
$2.88 M
|
| Cost And Expenses |
$105.61 M
|
$82.20 M
|
$123.48 M
|
$69.72 M
|
$12.89 M
|
$2.88 M
|
| Interest Income |
$7.04 M
|
$6.63 M
|
$2.76 M
|
$23.00 K
|
$66.00 K
|
$107.00 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$2.98 M
|
$1.93 M
|
$709.00 K
|
$647.00 K
|
$469.00 K
|
$0.00
|
| EBITDA |
-$65.51 M |
-$80.27 M |
-$122.77 M |
-$69.07 M |
-$12.43 M |
-$2.88 M |
| EBITDA Ratio |
-4.06
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-5.54
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$9.97 M
|
$8.41 M
|
$2.76 M
|
-$6.26 M
|
$0.00
|
$0.00
|
| Income Before Tax |
-$79.50 M
|
-$73.79 M
|
-$120.72 M
|
-$75.98 M
|
-$12.83 M
|
-$2.77 M
|
| Income Before Tax Ratio |
-4.92
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$2.16 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$77.33 M
|
-$73.79 M
|
-$120.72 M
|
-$75.98 M
|
-$12.83 M
|
-$2.77 M
|
| Net Income Ratio |
-4.79
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-1.32 |
-1.85 |
-3.57 |
-2.53 |
-0.37 |
-0.0777 |
| EPS Diluted |
-1.32 |
-1.85 |
-3.57 |
-2.53 |
-0.37 |
-0.0777 |
| Weighted Average Shares Out |
$58.45 M
|
$39.90 M
|
$33.03 M
|
$32.22 M
|
$34.31 M
|
$34.31 M
|
| Weighted Average Shares Out Diluted |
$58.45 M
|
$39.90 M
|
$33.03 M
|
$32.22 M
|
$34.31 M
|
$34.31 M
|
| Link |
|
|
|
|
|
|
